Cullinan Therapeutics Inc.

CGEM | NASDAQ

Price Alert Chart Builder DCF Calculator

$21.35

+$0.27 (+1.28%)

At close: Sep 21, 2026, 4:00 PM ET

$21.38

+$0.03 (+0.14%)

Pre-market: Sep 22, 2026, 8:16 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-219.88M	-167.58M	-153.16M	109.2M	-67.49M	-51.8M
Depreciation & Amortization	311K	306K	310K	93K	53K	62K
Stock-Based Compensation	36.04M	37.82M	30.44M	27.96M	24.38M	n/a
Other Working Capital	14.92M	423K	-172K	11.69M	1.29M	1.27M
Other Non-Cash Items	-6.31M	-15.47M	-11.52M	-275.09M	67K	15.11M
Deferred Income Tax	n/a	n/a	n/a	n/a	3.1M	n/a
Change in Working Capital	14.08M	-389K	-339K	11.18M	-3.54M	6.85M
Operating Cash Flow	-175.75M	-145.3M	-134.28M	-126.66M	-43.43M	-29.77M
Capital Expenditures	-49K	n/a	-208K	-1.13M	-589.23K	-10K
Cash Acquisitions	n/a	n/a	-36.01K	275M	923K	1.45M
Purchase of Investments	-236.53M	-721.13M	-373.38M	-377.92M	-525.81M	-69.76M
Sales Maturities Of Investments	416.57M	584.82M	409.4M	352.93M	192.04M	62.9M
Other Investing Acitivies	n/a	n/a	36.01K	91K	-333.78K	n/a
Investing Cash Flow	179.99M	-136.31M	35.81M	248.98M	-333.78M	-5.42M
Debt Repayment	n/a	n/a	1.83M	-2.2M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	3.54M	538K	-32.13M	1.52M	n/a
Financial Cash Flow	1.09M	266.19M	40.75M	-25.93M	268.78M	140.14M
Net Cash Flow	5.33M	-15.43M	-57.72M	96.38M	-108.42M	104.95M
Free Cash Flow	-175.8M	-145.3M	-134.48M	-127.8M	-44.02M	-29.78M
Adj. Free Cash Flow	-211.84M	-183.13M	-164.92M	-155.75M	-68.4M	-29.78M
Maintenance CapEx	-49K	n/a	-208K	-1.13M	n/a	-10K
Growth CapEx	n/a	n/a	n/a	n/a	-589.23K	n/a
Owner Earnings	-175.8M	-145.3M	-134.48M	-127.8M	-43.43M	-29.78M